Clinical Trial Update: Stereotactic Body Radiation Therapy With Boost Using Urethral-Sparing Intensity-Modulated Radiation Therapy Planning in Treating Patients With Prostate Cancer [NA]

View source ↗

Summary

Clinical trial investigating stereotactic body radiation therapy with a urethral-sparing intensity-modulated radiotherapy boost for Stage I–II prostate adenocar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma | NA | Status: COMPLETED